Express News | Adaptimmune Therapeutics PLC - Receives Nasdaq Notice for Non-Compliance With Minimum Bid Price
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
Express News | Adaptimmune Therapeutics: Entered Mutual Release and Resolution Agreement With Genentech Inc & F. Hoffmann-La Roche Ltd
Adaptimmune to Participate in Two Bank Conferences This September
Individual Investors Who Own 39% Along With Institutions Invested in Adaptimmune Therapeutics Plc (NASDAQ:ADAP) Saw Increase in Their Holdings Value Last Week
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading